Commercial Diligence
We are a trusted partner to biopharma and pharma services organizations for their buy and sell-side diligence. We provide comprehensive, data-driven commercial and scientific assessments to help clients gain a robust understanding of the market and identify opportunities to drive value.
Across our buy and sell-side commercial diligence projects, we employe a tailored approach to address specific questions at the right level of depth (e.g., robust evaluation for revenue-generating pharma services organization, higher level for early-stage sell-side evaluation). We develop detailed evaluations of the commercial, clinical, and scientific factors that affect the opportunity and outline factors that would enhance the commercial potential.
Our Approach
We adjust our approach to better answer each client’s strategic questions. However, the majority of our due diligence projects rely on five key steps with varying levels of robustness for each depending on the target focus (e.g., biopharma vs. pharma services) and stage (e.g., revenue-generating pharma services vs. pre-clinical therapeutic).
-
Strategic Questions
Refine key strategic questions to be addressed throughout the engagement and conduct a knowledge transfer from the client to our team to fully understand the target (asset, company, etc.)
-
Market Landscape Evaluation
Biopharma: Develop a thorough understanding of the disease overview, epidemiology, standard of care, patient journey, current market, pricing and market access, future pipeline, clinical hurdle rates, and unmet needs
Pharma Services: Understand key market trends, market positioning, pipeline analysis, share of wallet, contract value, and key growth levers
-
Stakeholder Insights
Conduct detailed discussions with key stakeholders to understand the current market dynamics, potential unmet needs, and future adoption
Key stakeholders may include: Physicians, Payers, Patients, Key Opinion Leaders, C-suite, Pharma Services Buyers
-
Commercial Assessment
Develop a range-based commercial model synthesizing the potential outcomes and areas of emphasis for future development to optimize growth potential
-
Synthesis and Recommendations
Synthesize the commercial opportunity for the appropriate audience (e.g., detailed evaluation for potential buy-side evaluation, synthesis for investment committee, high-level overview for sell-side Confidential Information Memorandum)